Clot

Clot - most related articles:

- Use of clot busters for stroke increased from 2005 to 2009 - 4.5
- Oral HRT doubles risk of blood clots - 3.5
- Clot busting treatment effective if given in 6 hours after a stroke - 3.4
- Warfarin may lead to brain bleeding following stroke treatment - 3.2
- Ablation heart procedure reduces risk of Alzheimer and stroke - 3
- Crestor reduced blood clots in the veins - 2.9
- Simple injection of TXA could save the lives of thousands of accident victims - 2.8
- Stroke rate declined in middle aged, elderly, increased in young - 2.5
- Poor oral hygiene, bleeding gums may cause heart disease - 2.2
- Heart disorder linked to Alzheimer's disease dementia - 2.1

Clot articles

Stent design may put patients at risk of heart attack
Stent shortening - a newly observed deformity in cases using a particular family of stents, can cause serious complications for patients, says researchers. In this case the stent clotted off and the patient had a heart attack.

Rivaroxaban can prevent strokes in atrial fibrillation patients
Rivaroxaban, an anti-clotting drug, was shown to be an attractive alternative to warfarin in the prevention of stroke in patients with atrial fibrillation, revealed by researchers recently.

Use of clot busters for stroke increased from 2005 to 2009
The use of clot-busting drugs to treat acute ischemic stroke increased from 2005 through 2009 - but is still low, according to research reported in Stroke: Journal of the American Heart Association.

Risk of blood clots from oral contraceptive pill
Researchers revealed that the combined oral contraceptive containing drospirenone carries a higher risk of venous thromboembolism than do formulations containing levonorgestrel.

Thigh length surgical stockings better to prevent blood clots
Treating hospital patients with thigh length surgical stockings, rather than knee-high socks, can reduce life threatening blood clots, a new study suggests.

Simple injection of TXA could save the lives of thousands of accident victims
If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year.

Warfarin may lead to brain bleeding following stroke treatment
Patients already taking warfarin who develop an acute stroke appear more likely to experience a brain hemorrhage following treatment with an intravenous clot-dissolving medication, even if their blood clotting function appears normal, revealed by researchers.

Weekend strokes may receive more aggressive treatment
Stroke patients admitted to the hospital on the weekend appear more likely to receive the clot-dissolving medication tissue plasminogen activator than patients admitted during the week. However, stroke death rates appear similar among weekend and weekday admissions.

Vaccine may cure chronic myeloid leukemia CML
Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).

Synthetic platelets halve clotting time, halt bleeding
Blood loss is a major cause of death from roadside bombs to freeway crashes. Traumatic injury, the leading cause of death for people age 4 to 44, often overwhelms the body's natural blood-clotting process.

Kalbitor, ecallantide, approved for treating hereditary angioedema
The U.S. Food and Drug Administration approved Kalbitor (ecallantide) to treat sudden and potentially life-threatening fluid buildup that can occur in people with a rare genetic condition known as hereditary angioedema (HAE).

Vioxx trial data shows early heart risk
US researchers revealed that the heart complications after taking Vioxx, the nonsteroidal anti-inflammatory drug (rofecoxib), could have been identified nearly four years before its manufacturer Merck pulled the drug from the market.

Gene variant linked to effectiveness of plavix
Patients with a certain genetic variation and who received the antiplatelet drug clopidogrel -- Plavix -- had a decreased platelet response to treatment, revealed by researchers.

Thalidomide does not improve survival in lung cancer
Treating patients with thalidomide in combination with chemotherapy for small cell lung cancer (SCLC) did not improve their survival but did increase their risk of blood clots, revealed by researchers.

Effient to reduce heart attack risk in angioplasty patients
The U.S. Food and Drug Administration has approved the Eli Lilly's blood-thinning drug Effient tablets (prasugrel) to reduce the risk of blood clots from forming in patients who undergo angioplasty, a common procedure to unblock a clogged coronary artery.

Improving heart attack treatment of patients
When faced with patients suffering a heart attack, doctors have two choices. One is to inject them with medication to dissolve the blood clot, that is fibrinolytic therapy, and second is to insert a small balloon to open the blocked artery i.e. primary percutaneous coronary intervention (PCI).

Option Inferior Vena Cava Filter gets FDA clearance in US
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Option(TM) Inferior Vena Cava (IVC) Filter in the United States, for use in both permanent and retrievable indications.

Green tea shows promise in leukemia
Mayo Clinic researchers are reporting positive results in early leukemia clinical trials using the chemical epigallocatechin gallate (EGCG), an active ingredient in green tea.

Benefits of anti clotting medications reduced by heartburn drugs
The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses, according to a new study presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 32nd Annual Scientific Sessions.

3 point plan to save money on insurance
Switching from brand names to generics is a great way to save money on food and clothes, but when it comes to insurance, consumers need to make well-informed decisions prior to altering coverage or changing companies.

Crestor reduced blood clots in the veins
A new analysis from the JUPITER study shows that CRESTOR (rosuvastatin calcium) 20mg significantly cut the risk of venous thromboembolism (VTE) by 43% compared to placebo among men and women with low to normal cholesterol levels and elevated high-sensitivity C-reactive protein (hsCRP).

Leukemia treatment developed in Australia
Two Australian research groups are undertaking pioneering studies into the causes of leukaemia, potentially leading to patients receiving new drug treatments as early as next year.

Ultrasound with tPA effective for stroke
An experimental therapy using tiny bubbles activated by transcranial Doppler (TCD) ultrasound combined with the clot busting drug tissue plasminogen activator (tPA) is more effective than tPA alone in treating patients suffering from ischemic stroke, according to new research presented at the American Stroke Association's International Stroke Conference in San Diego.

vCJD prion protein found in a patient with haemophilia at post mortem
The patient, who was over 70 years old, died of a condition unrelated to vCJD and had shown no symptoms of vCJD or any other neurological condition prior to his death. The vCJD abnormal prion protein was only identified during post mortem research tests.

ATryn from milk of goats approved to treat hereditary antithrombin deficiency
The U.S. Food and Drug Administration issued its first approval for a biological product produced by genetically engineered (GE) animals.

Women's fertility risk from exposure to perfluorinated chemicals
Researchers have found the first evidence that perfluorinated chemicals (PFCs) – chemicals that are widely used in everyday items such as food packaging, pesticides, clothing, upholstery, carpets and personal care products – may be associated with infertility in women.

Migraine linked to blood clots in veins, venous thrombosis
People with migraines may also be more likely to develop blood clots in their veins, and are more likely to have strokes and other cardiovascular problems, revealed by researchers.

Oral HRT doubles risk of blood clots
Hormone replacement therapy (HRT) given in skin patches may cause fewer blood clots than HRT given orally, revealed by researchers in British Medical Journal, UK. Women who take the oral form of HRT more than double their risk of developing a blood clot.

Prasugrel cuts risk of stent-related clots
The investigational antiplatelet drug prasugrel plus aspirin produced a marked and highly statistically significant reduction in the risk of coronary stent thrombosis (ST) - a major concern for physicians and patients with potentially fatal consequences - in patients who received a stent as compared to standard therapy with clopidogrel (Plavix) plus aspirin, according to a stent analysis from the head-to-head TRITON-TIMI 38 trial.

Germany recalls heparin blood anticoagulant
More than 70 peoples fell sick because of heaprin injections used during dialysis medical procedure for their kidney problems, reported by German health authorities.

Does ginkgo biloba affect memory?
Taking the supplement ginkgo biloba had no clear-cut benefit on the risk of developing memory problems, according to a study published in the February 27, 2008, online issue of Neurology, the medical journal of the American Academy of Neurology.

Clot busting treatment effective if given in 6 hours after a stroke
The study, co-ordinated by the Royal Melbourne Hospital and conducted by the Australasian Stroke Trialists Network including the Hunter Medical Research Institute (HMRI) Stroke Research Group demonstrates that clot busting (thrombolysis) treatment can be effective when administered up to six hours after a stroke.

Anemia drugs for cancer patients raises blood clots risk
Treating anemia with a class of drugs known as erythropoiesis-stimulating agents (ESAs) is associated with an increased risk of venous thromboembolism (blood clots in the deep veins of the legs or in the lungs) and death among patients with cancer, according to an article in the February 27 issue of JAMA.

Baxter's multiple-dose vial Heparin causing allergy
The U.S. Food and Drug Administration announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug.

New research into scar-free faster healing
New research from the University of Bristol shows that by suppressing one of the genes that normally switches on in wound cells, wounds can heal faster and reduce scarring. This has major implications not just for wound victims but also for people who suffer organ tissue damage through illness or abdominal surgery.

Aspirin resistance increases heart attack, stroke risk
Being resistant to aspirin makes patients four times more likely to suffer a heart attack, stroke or even die from a pre-existing heart condition, according to a study published in British Medical Journal, UK. The study relates to patients who are prescribed aspirin long term as a way of preventing clots from forming in the blood.

Ortho Evra contraceptive transdermal birth control patch label update
The U.S. Food and Drug Administration (FDA) approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills. VTE can lead to pulmonary embolism.

37 Clot articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
9.34